Uno S - Search Results

1

Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: a subgroup analysis of the STELLA-LONG TERM study (3-month interim results).

Tabuchi H, Maegawa H, Tobe K, Nakamura I, Uno S. Tabuchi H, et al. Among authors: uno s. Endocr J. 2019 Jan 28;66(1):31-41. doi: 10.1507/endocrj.EJ18-0217. Epub 2018 Nov 3. Endocr J. 2019. PMID: 30393249 Free article.

2

Safety, efficacy, and persistence of long-term mirabegron treatment for overactive bladder in the daily clinical setting: Interim (1-year) report from a Japanese post-marketing surveillance study.

Kato D, Tabuchi H, Uno S. Kato D, et al. Among authors: uno s. Low Urin Tract Symptoms. 2019 Jan;11(1):14-23. doi: 10.1111/luts.12188. Epub 2017 Aug 1. Low Urin Tract Symptoms. 2019. PMID: 28762672

3

Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study.

Nakamura I, Maegawa H, Tobe K, Tabuchi H, Uno S. Nakamura I, et al. Among authors: uno s. Expert Opin Pharmacother. 2018 Feb;19(3):189-201. doi: 10.1080/14656566.2017.1408792. Epub 2017 Dec 22. Expert Opin Pharmacother. 2018. PMID: 29185822

4

Safety and efficacy of ipragliflozin in elderly versus non-elderly Japanese patients with type 2 diabetes mellitus: a subgroup analysis of the STELLA-LONG TERM study.

Maegawa H, Tobe K, Tabuchi H, Nakamura I, Uno S. Maegawa H, et al. Among authors: uno s. Expert Opin Pharmacother. 2018 Mar;19(4):327-336. doi: 10.1080/14656566.2018.1434145. Epub 2018 Mar 5. Expert Opin Pharmacother. 2018. PMID: 29388470

5

Three-year safety, efficacy and persistence data following the daily use of mirabegron for overactive bladder in the clinical setting: A Japanese post-marketing surveillance study.

Kato D, Tabuchi H, Uno S. Kato D, et al. Among authors: uno s. Low Urin Tract Symptoms. 2019 Apr;11(2):O152-O161. doi: 10.1111/luts.12237. Epub 2018 Aug 5. Low Urin Tract Symptoms. 2019. PMID: 30079630 Free PMC article.

6

Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3-month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long-term Use study.

Tobe K, Maegawa H, Tabuchi H, Nakamura I, Uno S. Tobe K, et al. Among authors: uno s. J Diabetes Investig. 2019 Sep;10(5):1262-1271. doi: 10.1111/jdi.13021. Epub 2019 Mar 25. J Diabetes Investig. 2019. PMID: 30719865 Free PMC article.

7

Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study.

Nakamura I, Maegawa H, Tobe K, Uno S. Nakamura I, et al. Among authors: uno s. Adv Ther. 2019 Apr;36(4):923-949. doi: 10.1007/s12325-019-0895-1. Epub 2019 Feb 14. Adv Ther. 2019. PMID: 30767112 Free PMC article.

8

Safety and effectiveness of ipragliflozin in elderly versus non-elderly Japanese type 2 diabetes mellitus patients: 12 month interim results of the STELLA-LONG TERM study.

Maegawa H, Tobe K, Nakamura I, Uno S. Maegawa H, et al. Among authors: uno s. Curr Med Res Opin. 2019 Nov;35(11):1901-1910. doi: 10.1080/03007995.2019.1647503. Epub 2019 Aug 29. Curr Med Res Opin. 2019. PMID: 31347926 Free article.

9

Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post-marketing study.

Takahashi S, Kato D, Tabuchi H, Uno S. Takahashi S, et al. Among authors: uno s. Low Urin Tract Symptoms. 2021 Jan;13(1):79-87. doi: 10.1111/luts.12335. Epub 2020 Aug 5. Low Urin Tract Symptoms. 2021. PMID: 32761776 Free PMC article.

10

Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM).

Nakamura I, Maegawa H, Tobe K, Uno S. Nakamura I, et al. Among authors: uno s. Expert Opin Pharmacother. 2021 Feb;22(3):373-387. doi: 10.1080/14656566.2020.1817388. Epub 2020 Oct 3. Expert Opin Pharmacother. 2021. PMID: 33012212 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

700 results

Search Page

Filters